Quince Therapeutics (QNCX) Balance Sheet: Assets & Liabilities

Quince Therapeutics (QNCX) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Quince Therapeutics reported total assets of $93.52M and total liabilities of $129.24M. Shareholders' equity was negative at −$35.71M, meaning liabilities exceed assets. Total debt stood at $18.47M against $17.75M in cash and short-term investments, a net debt position of $719.00K.

Quince Therapeutics Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Quince Therapeutics, Inc. (QNCX) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Mar 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Current Assets
Cash and Cash Equivalents	5.81	6.21	20.75	20.75	44.58	69.72	66.84	51.21	24.87	7.34
Short-Term Investments	11.94	34.57	54.31	54.31	45.60	37.08	66.98	48.65	46.84	0.00
Cash & Short-Term Investments	17.75	40.78	75.06	75.06	90.18	106.80	133.82	99.86	71.72	7.34
Accounts Receivable	3.62	0.88	0.99	0.99	1.00	1.13	0.00	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	-	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	1.52	2.37	1.39	2.38	3.57	3.74	1.24	6.19	0.87	0.19
Total Current Assets	22.90	44.04	77.44	77.44	93.75	111.67	137.86	106.06	72.59	7.54
Non-Current Assets
Property, Plant & Equipment (Net)	1.05	0.81	0.62	0.62	0.68	1.43	1.10	1.33	0.28	0.12
Long-Term Investments	0.08	0.08	0.08	0.08	3.58	19.93	50.46	16.76	0.00	0.00
Goodwill	0.00	0.00	17.63	17.63	0.00	0.00	0.00	0.00	0.00	0.00
Intangible Assets	67.82	60.05	63.67	63.67	5.90	0.00	0.00	0.00	0.00	0.00
Other Non-Current Assets	1.68	9.51	8.47	8.54	3.58	0.19	0.04	0.22	0.01	0.06
Total Non-Current Assets	70.63	70.44	102.76	90.46	10.16	21.56	51.60	18.31	0.29	0.18
Total Assets	93.52	114.48	180.20	167.90	103.91	133.23	189.47	124.37	72.88	7.72
Current Liabilities
Accounts Payable	2.22	2.90	2.03	2.03	0.57	4.91	3.56	3.08	0.50	0.52
Short-Term Debt	18.14	0.10	0.06	-	0.45	0.74	0.24	0.00	0.00	0.00
Current Portion of Long-Term Debt	18.03	-	-	-	-	-	-	-	-	-
Accrued Liabilities	10.29	3.97	-	3.44	2.50	9.31	13.16	-	-	-
Other Current Liabilities	22.86	4.28	7.48	4.10	0.19	8.57	0.04	5.82	0.96	1.25
Total Current Liabilities	43.23	7.28	9.57	9.57	3.07	14.22	17.00	8.89	1.46	1.76
Non-Current Liabilities
Long-Term Debt	0.33	14.72	13.75	13.43	0.00	0.42	0.21	0.00	0.00	7.17
Deferred Tax Liabilities	0.00	4.96	17.61	5.30	0.25	0.00	0.00	0.00	0.00	0.00
Other Non-Current Liabilities	85.68	57.38	54.19	59.49	0.25	0.00	0.00	0.00	0.00	19.06
Total Non-Current Liabilities	86.01	77.05	85.55	73.24	0.25	0.42	0.21	3.08	0.50	26.24
Total Liabilities	129.24	84.33	95.12	82.82	3.32	14.64	17.20	8.89	1.46	28.00
Stockholders' Equity
Common Stock	0.06	0.04	0.04	0.04	0.04	0.03	0.03	0.03	0.02	0.00
Retained Earnings	-460.45	-376.47	-319.64	-319.64	-288.26	-236.60	-146.65	-69.81	-32.83	-20.35
Accumulated Other Comprehensive Income	5.75	-0.04	3.05	3.05	-0.29	-0.08	0.31	0.06	-0.05	-17.18
Additional Paid-in Capital	418.93	406.61	401.64	401.64	389.11	355.23	318.57	185.20	0.03	0.07
Shares Outstanding	0.28	0.22	-	0.21	0.18	30.07	-	-	-	-
Total Stockholders' Equity	-35.71	30.15	85.08	85.08	100.59	118.59	172.26	115.48	71.42	-20.28
Total Liabilities & Equity	93.52	114.48	180.20	167.90	103.91	133.23	189.47	124.37	72.88	7.72

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Quince Therapeutics Balance Sheet

How much debt does Quince Therapeutics have?

Quince Therapeutics had total debt of $18.47M as of Dec 31, 2025, against $17.75M in cash and short-term investments. Total debt was $14.81M a year earlier.

What are Quince Therapeutics's total assets?

Quince Therapeutics reported total assets of $93.52M as of Dec 31, 2025, down 18.3% from $114.48M a year earlier. Total liabilities were $129.24M.

What is Quince Therapeutics's shareholders' equity?

Quince Therapeutics's shareholders' equity was negative at −$35.71M as of Dec 31, 2025, so its liabilities exceeded its assets.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition